JOINT FILING AGREEMENTJoint Filing Agreement • July 27th, 2012 • Platinum Partners Value Arbitrage Fund, LP • In vitro & in vivo diagnostic substances
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13G and all amendments thereto with respect to the Common Stock, par value $0.001 per share, of Navidea Biopharmaceuticals, Inc. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.
